FCI
PETX

Financial Counselors Inc’s Aratana Therapeutics, Inc. PETX Stock Holding History

Financial Counselors Inc’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,000
Closed -$116K – 507
2017
Q3 		$116K Hold
19,000
– – 0.01% 481
2017
Q2 		$137K Hold
19,000
– – 0.01% 483
2017
Q1 		$101K Buy
+19,000
New +$128K 0.01% 488

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Financial Counselors Inc's PETX Position: Q4 2017 in Review

Financial Counselors Inc sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2017, closing a stake of 19,000 shares — an estimated $116K sold.

Financial Counselors Inc first reported a position in PETX in Q1 2017 and held it in 3 quarters. The position peaked at $137K in Q2 2017. 105 funds tracked by Wall St. Rank hold PETX as of Q4 2017.

  • Financial Counselors Inc reported no remaining Aratana Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Financial Counselors Inc sold 19,000 Aratana Therapeutics, Inc. shares in Q4 2017, an estimated $116K.
  • Financial Counselors Inc first reported a position in Aratana Therapeutics, Inc. in Q1 2017 and held it in 3 quarters.
  • Financial Counselors Inc's Aratana Therapeutics, Inc. position peaked at $137K in Q2 2017.
  • 105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2017.

Based on Financial Counselors Inc's 13F filing for Q4 2017, filed 12 Feb 2018.